gvtcx

supplier

Sobi (Swedish Orphan Biovitrum Ltd)

CB216AD

as a supplier

22 recorded awards from 2 buyers , between 7 Feb 2022 and 30 Jun 2025.

awards won
22
exclusive
0%
0 sole-winner awards
median award
£480.4m
largest
£986.3m

“Exclusive” means this organisation was the only one awarded under that procurement; the rest were shared with other suppliers, typically on a framework.

sells to

buyerawards
NHS England 16
The NHS Commissioning Board (operating under the name of NHS England) 6

contracts won

contractbuyervalueawarded
NHS Branded Medicines Tranche B - MAE & NOFE - 1 September 2025 shared NHS England £986,282,758 30 Jun 2025
NHS National Generic Pharmaceuticals Wave 14c (CF Award - Part 1) shared NHS England £1 4 Mar 2024
NHS Midland & East Branded Medicines, Tranche B & Annual Tranche shared NHS England £480,429,000 13 Feb 2023
NHS Framework for North of England Branded Medicines Tranche A & Annual Tranche shared NHS England £261,970,000 8 Feb 2023
NHS Framework for the North of England, Branded Medicine shared NHS England £238,913,892 7 Feb 2022
NHS Framework for the North of England, Branded Medicine shared NHS England £238,913,892 7 Feb 2022
NHS Framework for the North of England, Branded Medicine shared NHS England £238,913,892 7 Feb 2022
NHS Framework for Midlands and East, Branded Medicines - Tranche A and Annual shared NHS England £216,078,796 7 Feb 2022
NHS National Generic Pharmaceuticals Wave 15b shared NHS England · 4 Aug 2025
NHS Framework - Blood Disorders including Haemophilia A and B - July 2024 shared NHS England · 11 Jun 2024
NHS Framework - Blood Disorders including Haemophilia A and B - July 2024 shared NHS England · 11 Jun 2024
NHS North of England Branded Medicines Tranche A & Annual Tranche shared NHS England · 15 Mar 2023
NHS Framework Agreement for South of England Branded - Tranche B and Annual shared NHS England · 12 Aug 2022
NHS Framework Agreement for London, Branded Medicines - Tranche A and Annual shared NHS England · 11 Aug 2022
NHS Framework for the North of England, Branded Medicine shared The NHS Commissioning Board (operating under the name of NHS England) · 1 Mar 2022
NHS Framework for Midlands and East, Branded Medicines – Tranche A and Annual shared The NHS Commissioning Board (operating under the name of NHS England) · 22 Feb 2022
NHS National Generic Pharmaceuticals Wave 13 shared The NHS Commissioning Board (operating under the name of NHS England) · 14 Jan 2022
NHS Framework Agreement, Branded Medicines for London and South of England shared NHS England · 17 Sept 2021
NHS Framework Agreement, Branded Medicines for London and South of England shared NHS England · 17 Sept 2021
NHS Framework for the Midlands and East, Branded Medicines – Tranche B plus Cytokine Modulators and other Monoclonal Antibodies. shared The NHS Commissioning Board (operating under the name of NHS England) · 23 Feb 2021
NHS Framework for the Midlands and East, Branded Medicines – Tranche B plus Cytokine Modulators and other Monoclonal Antibodies. shared The NHS Commissioning Board (operating under the name of NHS England) · 23 Feb 2021
NHS Framework for the Midlands and East, Branded Medicines – Tranche B plus Cytokine Modulators and other Monoclonal Antibodies. shared The NHS Commissioning Board (operating under the name of NHS England) · 23 Feb 2021

every contract won by Sobi (Swedish Orphan Biovitrum Ltd) →